Programme

The workshop includes several lectures of the well-known experts in the field.

Thursday 21.5.2026

Moderator

08.45-08.55 Welcome and Introduction to the Workshop; Outi Mäkitie, Finland
08.55-09.25 Skeletal dysplasias - The Nosology and disease spectrum; Geert Mortier, Belgium
09.25-09:50 An update on genetic tools; Giedre Grigelioniene, Sweden
09.50-10.15 Case presentations: Norwegian cases; TBA
10.15-10.30 COFFEE
10.30-11.00 What is new in osteogenesis imperfecta?; Outi Mäkitie, Finland
11.00-11.25 Dental and oral manifestations of OI; Heidi Arponen, Finland
11.25-11.50 Quality of life in patients with OI; Lena Lande Wekre, Norway
11.50-12.15 Case presentations: Danish cases; TBA
12.15-13.15 LUNCH, ,

Moderator

13.15-13.45 Achondroplasia - un update on novel treatments; Svein Fredwall, Norway
13.45-14.15 What is new in hypochondroplasia; Laurence Legeai-Mallet, France
14.15-14.40 Case presentations: Swedish cases; TBA
14.40-15:00 COFFEE
15.00-15.25 Enzyme replacement therapies in metabolic bone diseases; Harri Niinikoski, Finland
15.25-15.50 Spinal problems and orthopedic management; Ilkka Helenius, Finland
15.50-16.15 Research presentations; TBA

***

Friday 22.5.2026

Moderator TBA

08.30-09.00 Prenatal diagnostics in skeletal dysplasia; Laura Tanner, Finland
09.00-09.30 Radiological overview of GAG synthesis disorders; Gen Nishimura, Japan
09.30-09.50 Mulibrey nanism - Skeletal manifestations; Susann Karlberg, Finland
09.50-10.15 Case presentations: Case presentations: Finnish cases; Saila Laakso, Helena Valta
10.15-10.30 COFFEE
10.30-11.00 Novel genetic forms of short stature; Mari Muurinen, Finland
11.00-11.30 High bone mass disorders?; ?/TBA
11.30-12.00 Patient perspective; TBA
12.00-13.00 LUNCH, ,

Moderator TBA

13.00-13.40 Hypophosphatemic rickets and effects of burosumab; Thomas Carpenter, USA
13.40-14.00 Burosumab in children - the Finnish experience; Helena Valta, Finland
14.00-14.45 Research presentations; TBA
14.45-15.00 Concluding remarks; Outi Mäkitie, Finland